Date: 11/13/2008
LONDON (AP) _ Pharmaceutical company AstraZeneca PLC said Thursday European regulators have approved a new version of its bipolar disorder drug Seroquel.
The drug company said a once-daily formulation, Seroquel XR, has been approved by the European Mutual Recognition Procedure for new indications in bipolar disorder and moderate to severe manic episodes in bipolar disorder.
Bipolar disorder causes dramatic mood swings, from deep depression to manic highs. AstraZeneca shares rose 1.7 percent to close at 2,837 pence ($41.55) in London.
Copyright 2008 The Associated Press.
AstraZeneca receives approval for bipolar drug
Posted on 13th November 2008 by Gordon Johnson in Uncategorized
AstraZeneca, Bipolar disorder, drug news, manic episodes, manic highs, mood swings, pharmaceuticals
- Black Music Impressario Don Cornelius, His Brain Surgery And Suspected Suicide
- Princeton Freshman Football Star Dibilio Recovering From Stroke
- Illinois Man Thinks It’s A Joke When He Learns He Shot A Nail Into His Brain
- New York Mets Great Gary Carter Has New Brain Tumors
- Therapists Try To Find Ways To Help Married Couples Cope With TBI
- Jessica Joy Rees, Child Brain Tumor Blogger, Never Gave Up
- Arizona Man Comes Out of Coma, Before Being Groomed To Be An Organ Donor
- Texas Model Recovering, But Could Lose Eye, After Walking Into Plane Propeller
- Wisconsin Study Finds Violent Video Games Cause Brain Changes
- Ex-Sen. George McGovern Hospitalized After Hitting Head In Fall
Please click here to download the plugin required to make popular posts work!
Follow Us
Archives